IL-1β hampers glucose-stimulated insulin secretion in Cohen diabetic rat islets through mitochondrial cytochrome c oxidase inhibition by nitric oxide

Am J Physiol Endocrinol Metab. 2014 Mar;306(6):E648-57. doi: 10.1152/ajpendo.00451.2013. Epub 2014 Jan 14.

Abstract

A high-sucrose, low-copper-diet (HSD) induces inhibition of glucose-sensitive rats (CDs) but not Cohen diabetes-resistant rats (CDr). Copper-supplemented HSD increased activity of the copper-dependent mitochondrial respiratory chain enzyme cytochrome c oxidase (COX) and reversed hyperglycemia. This study examined the mechanism by which interleukin-1β modulates GSIS and the role of COX in this process. We measured COX activity, ATP content, GSIS, iNOS expression, and nitrite production with and without IL-1β, N(ω)-nitro-l-arginine, copper, or potassium cyanide in isolated islets of CDs and CDr fed different diets. We found reduced COX activity, ATP content, and GSIS in isolated islets of CDs rats fed a regular diet. These were severely reduced following HSD and were restored to regular diet levels on copper-supplemented HSD (P < 0.01 vs. CDr islets). Potassium cyanide chemically reduced COX activity, decreasing GSIS and thus reinforcing the link between islet COX activity and GSIS. Interleukin-1β (2.5 U/ml) reduced GSIS and COX activity in CDs islets. Exposure to 10 U/ml interleukin-1β decreased GSIS and COX activity in both CDs and CDr islets, inducing a similar nitrite production. Nevertheless, the effect on GSIS was more marked in CDs islets. A significant iNOS expression was detected in CDs on the HSD diet, which was reduced by copper supplementation. N(ω)-nitro-l-arginine and copper prevented the deleterious effect of interleukin-1β on COX activity and GSIS. We conclude that reduced islet COX activity renders vulnerability to GSIS inhibition on low-copper HSD through two interrelated pathways: 1) by further reducing the activity of COX that is essential for β-cell ATP-production and insulin secretion and 2) by inducing the expression of iNOS and nitric oxide-mediated COX inhibition. We suggest that islet COX activity must be maintained above a critical threshold to sustain adequate GSIS with exposure to low-copper HSD.

Keywords: copper; cytochrome c oxidase; inducible nitrix oxide synthase; interleukin-1β; pancreatic β-cell.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Copper / deficiency
  • Copper / metabolism
  • Copper / therapeutic use
  • Diabetes Mellitus, Type 2 / etiology
  • Diabetes Mellitus, Type 2 / metabolism*
  • Diabetes Mellitus, Type 2 / prevention & control
  • Dietary Sucrose / adverse effects
  • Disease Models, Animal*
  • Electron Transport Complex IV / antagonists & inhibitors*
  • Electron Transport Complex IV / metabolism
  • Enzyme Inhibitors / pharmacology
  • Glucose / metabolism
  • Hyperglycemia / metabolism
  • Hyperglycemia / prevention & control
  • Insulin / metabolism*
  • Insulin Resistance
  • Insulin Secretion
  • Interleukin-1beta / metabolism*
  • Islets of Langerhans / drug effects
  • Islets of Langerhans / metabolism*
  • Male
  • Nitric Oxide / metabolism*
  • Nitric Oxide Synthase Type II / antagonists & inhibitors
  • Nitric Oxide Synthase Type II / metabolism
  • Osmolar Concentration
  • Rats
  • Rats, Inbred Strains
  • Tissue Culture Techniques

Substances

  • Dietary Sucrose
  • Enzyme Inhibitors
  • Insulin
  • Interleukin-1beta
  • Nitric Oxide
  • Copper
  • Nitric Oxide Synthase Type II
  • Nos2 protein, rat
  • Electron Transport Complex IV
  • Glucose